Latest news with #Mirion
Business Wire
21-07-2025
- Business
- Business Wire
Mirion Technologies Unveils the Vital Platform, a Digital Ecosystem Powering Integrated Operations for Nuclear Energy and Beyond
ATLANTA--(BUSINESS WIRE)-- Mirion Technologies, a leading provider of advanced radiation safety solutions, announced the launch of the Vital Platform. This software offers a single, unified system for accessing data across nuclear power sites to work more efficiently, enhance worker safety, and solve operational challenges faster. The launch includes the platform's first application, Vital Supervision, designed to enhance radiological instrument data visibility, improve response times, and simplify oversight across critical radiological systems. The Vital Platform was developed to meet nuclear industry demands for a more connected and efficient way to manage radiological instrument data. Rather than relying on fragmented systems or manual processes, Vital enables teams to work within one streamlined environment prioritizing speed, security, and long-term adaptability. 'This digital offering represents a significant leap forward in radiation safety and management and is driven by demand for a comprehensive, transformative solution tailor-made for critical environments,' said Thomas Logan, CEO of Mirion. 'Vital is a critical enabler of advancements taking place at Mirion in our digital and physical portfolio of solutions for nuclear power and related fields.' Key benefits to customers include: Data Integration and Real Time Monitoring: Real-time tracking across systems enables faster, proactive responses. Regulatory Compliance and Reporting: Automated, standardized reporting simplifies regulatory alignment. Operational Efficiency and Cost Reduction: Streamlined workflows cut time, reduce errors, and lower costs. Security and Risk Mitigation: Access controls and cybersecurity safeguard sensitive data. Facilitating Advanced Analytics: Detailed data helps predict risks and improve decision-making. Scalability and Future Proofing: Modular design supports growth and adapts to change. Supervision: The First Vital Platform Application Vital Supervision is the first in a series of applications to be built on the Vital Platform, with the aim to unify the capabilities of siloed, standalone software into one platform. This application simplifies the collection and analysis of data from a wide variety of radiological instruments. Real-time, at-a-glance access to alarms, measurement data and instrument health significantly enhances the monitoring and management of critical equipment. The Vital Platform and Vital Supervision application will be showcased at two key upcoming industry events. A webinar presentation facilitated through Nuclear Engineering International (July 23) and Mirion's annual users' conference Mirion Connect (July 28-August 1) will offer opportunities to explore platform capabilities in depth. About Mirion Mirion is a global leader in radiation safety, science and medicine, empowering innovations that deliver vital protection while harnessing the transformative potential of ionizing radiation across a diversity of end markets. Focused on nuclear and safety, the Mirion Technologies group is committed to powering advancements in nuclear energy through proven radiation safety technologies and expertise. Dedicated to driving better patient outcomes, the Mirion Medical group is focused on improving quality in cancer care through its broad range of solutions that enhance the delivery and ensure safety across the medical landscape. Headquartered in Atlanta (GA – USA), Mirion employs approximately 2,800 people and operates in 12 countries. Learn more at
Business Wire
17-07-2025
- Business
- Business Wire
Mirion Announces Earnings Release and Conference Call Date for Second Quarter 2025
ATLANTA--(BUSINESS WIRE)--Mirion (NYSE: MIR) announced today that it will release financial results for second quarter 2025 after market close on Thursday, July 31, 2025. Following the news release, the company will host a conference call the next day, Friday, August 1, 2025, at 10:00 am ET to discuss the results. Participants may access the call by dialing 1-877-407-9208 or 1-201-493-6784, and requesting to join the Mirion Technologies, Inc. earnings call. A live webcast will also be available at A telephonic replay will be available shortly after the conclusion of the call and until August 15, 2025. Participants may access the replay at 1-844-512-2921 or 1-412-317-6671 with access code 13754545. An archived replay of the call will also be available on the Investors portion of the Mirion website at About Mirion Mirion (NYSE: MIR) is a global leader in radiation safety, science and medicine, empowering innovations that deliver vital protection while harnessing the transformative potential of ionizing radiation across a diversity of end markets. The Mirion Nuclear & Safety group provides proven radiation safety technologies that operate with precision – for essential work within R&D labs, critical nuclear facilities, and on the front lines. The Mirion Medical group solutions help enhance the delivery and ensure safety in healthcare, powering the fields of Nuclear Medicine, Radiation Therapy QA, Occupational Dosimetry, and Diagnostic Imaging. Headquartered in Atlanta (GA – USA), Mirion employs approximately 2,800 people and operates in 12 countries. Learn more at
Yahoo
27-06-2025
- Business
- Yahoo
Specialized Technology Stocks Q1 Teardown: Mirion (NYSE:MIR) Vs The Rest
The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let's take a look at how specialized technology stocks fared in Q1, starting with Mirion (NYSE:MIR). Companies in this sector, especially if they invest wisely, could see demand tailwinds as the world moves towards more IoT (Internet of Things), automation, and analytics. Enterprises across most industries will balk at taking these journeys solo and will enlist companies with expertise and scale in these areas. However, headwinds could include rising competition from larger technology firms, as digitization lowers barriers to entry in the space. Additionally, companies in the space will likely face evolving regulatory scrutiny over data privacy, particularly for surveillance and security technologies. This could make companies have to continually pivot and invest. The 8 specialized technology stocks we track reported a strong Q1. As a group, revenues beat analysts' consensus estimates by 1.3% while next quarter's revenue guidance was in line. Luckily, specialized technology stocks have performed well with share prices up 25.5% on average since the latest earnings results. With its technology protecting workers in over 130 countries and equipment used in 80% of cancer centers worldwide, Mirion Technologies (NYSE:MIR) provides radiation detection, measurement, and monitoring solutions for medical, nuclear energy, defense, and scientific research applications. Mirion reported revenues of $202 million, up 4.9% year on year. This print exceeded analysts' expectations by 0.6%. Overall, it was an exceptional quarter for the company with a solid beat of analysts' EPS estimates and an impressive beat of analysts' full-year EPS guidance estimates. 'We delivered a strong start to the year, with year-over-year revenue growth and adjusted free cash flow generation,' commented Mirion's Chairman and Chief Executive Officer Thomas Logan. Interestingly, the stock is up 38.4% since reporting and currently trades at $21.55. Is now the time to buy Mirion? Access our full analysis of the earnings results here, it's free. Originally spun off from networking equipment maker Netgear in 2018, Arlo Technologies (NYSE:ARLO) provides cloud-based smart security devices and subscription services that help consumers and businesses monitor and protect their homes, properties, and loved ones. Arlo Technologies reported revenues of $119.1 million, down 4.1% year on year, outperforming analysts' expectations by 0.6%. The business had an exceptional quarter with an impressive beat of analysts' EPS estimates. The market seems happy with the results as the stock is up 62% since reporting. It currently trades at $17.27. Is now the time to buy Arlo Technologies? Access our full analysis of the earnings results here, it's free. Taking its name from the black and white stripes of barcodes, Zebra Technologies (NASDAQ:ZBRA) provides barcode scanners, mobile computers, RFID systems, and other data capture technologies that help businesses track assets and optimize operations. Zebra reported revenues of $1.31 billion, up 11.3% year on year, exceeding analysts' expectations by 1.4%. Still, it was a slower quarter as it posted a significant miss of analysts' EPS guidance for next quarter estimates and revenue guidance for next quarter meeting analysts' expectations. Interestingly, the stock is up 27.1% since the results and currently trades at $309.50. Read our full analysis of Zebra's results here. Protecting everything from schools to government facilities since 1969, Napco Security Technologies (NASDAQ:NSSC) manufactures electronic security devices, access control systems, and communication services for intrusion and fire alarm systems. Napco reported revenues of $43.96 million, down 10.8% year on year. This result beat analysts' expectations by 1.9%. Overall, it was an exceptional quarter as it also logged a solid beat of analysts' EPS estimates. Napco had the slowest revenue growth among its peers. The stock is up 25.5% since reporting and currently trades at $29.85. Read our full, actionable report on Napco here, it's free. Born from a corporate transformation completed in 2023, Crane NXT (NYSE:CXT) provides specialized technology solutions for payment processing, banknote security, and authentication systems for financial institutions and businesses. Crane NXT reported revenues of $330.3 million, up 5.3% year on year. This number topped analysts' expectations by 3.9%. Overall, it was a very strong quarter as it also produced a solid beat of analysts' organic revenue estimates and a decent beat of analysts' EPS estimates. Crane NXT achieved the biggest analyst estimates beat among its peers. The stock is up 16.6% since reporting and currently trades at $55.58. Read our full, actionable report on Crane NXT here, it's free. In response to the Fed's rate hikes in 2022 and 2023, inflation has been gradually trending down from its post-pandemic peak, trending closer to the Fed's 2% target. Despite higher borrowing costs, the economy has avoided flashing recessionary signals. This is the much-desired soft landing that many investors hoped for. The recent rate cuts (0.5% in September and 0.25% in November 2024) have bolstered the stock market, making 2024 a strong year for equities. Donald Trump's presidential win in November sparked additional market gains, sending indices to record highs in the days following his victory. However, debates continue over possible tariffs and corporate tax adjustments, raising questions about economic stability in 2025. Want to invest in winners with rock-solid fundamentals? Check out our Hidden Gem Stocks and add them to your watchlist. These companies are poised for growth regardless of the political or macroeconomic climate. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Business Wire
24-06-2025
- Business
- Business Wire
Mirion Technologies and Westinghouse Partner to Drive Digital Innovation in Nuclear Instrumentation Systems
ATLANTA--(BUSINESS WIRE)-- Mirion Technologies (NYSE: MIR), a leading provider of advanced radiation safety solutions, and Westinghouse Electric Company LLC, a leading supplier of nuclear plant instrumentation and control systems, have announced a strategic partnership to provide digital Ex-core Nuclear Instrumentation Systems (NIS) based on the high-performing Mirion proTK product line. This collaboration aims to alleviate operator and maintenance burdens, enhance performance, and ensure sustained operation success. This digital NIS upgrade solution is offered exclusively through Westinghouse for both Westinghouse and Combustion Engineering designed PWRs worldwide. This initiative leverages Mirion's proTK product line to upgrade existing analog neutron flux monitoring drawers, which were originally designed in the 1960s, to a state-of-the-art digital system. The Mirion proTK product line represents an advanced and reliable Ex-core neutron flux measurement solution to replace the outdated equipment that can be costly and labor-intensive to maintain. Additionally, the Westinghouse and Mirion collaboration provides a drop-in replacement for legacy systems, minimizing disruptions to operations and training. With over 400 drawers implemented globally, reflecting more than 4000 operating years, Mirion's proTK product line has a proven track record for reliability and performance in nuclear facilities of any size and complexity. 'At Mirion, we are committed to advancing the nuclear industry through proven radiation safety technologies and expertise, and this partnership with Westinghouse underscores the importance of digital innovation.' said Loic Eloy, President of Mirion Technologies Group. 'The integration of our proTK technology into the Westinghouse-designed fleet will bring unparallelled reliability and accuracy. We are excited to support the long-term success of the Westinghouse nuclear footprint through this initiative.' For more information about Westinghouse and this digital NIS upgrade offering, please visit To learn more about Mirion's proTK product line, visit About Mirion Mirion (NYSE: MIR) is a global leader in radiation safety, science and medicine, empowering innovations that deliver vital protection while harnessing the transformative potential of ionizing radiation across a diversity of end markets. Focused on nuclear and safety, the Mirion Technologies group is committed to powering advancements in nuclear energy through proven radiation safety technologies and expertise. Dedicated to driving better patient outcomes, the Mirion Medical group is focused on improving quality in cancer care through its broad range of solutions that enhance the delivery and ensure safety across the medical landscape. Headquartered in Atlanta (GA – USA), Mirion employs approximately 2,800 people and operates in 12 countries. Learn more at
Business Wire
19-06-2025
- Business
- Business Wire
Mirion Medical to Debut New Solutions, Highlight Broad Radiopharma-Focused Portfolio at SNMMI Annual Meeting
ATLANTA--(BUSINESS WIRE)-- Mirion, a global leader in radiation safety, science, and medicine, announced today that its Mirion Medical group will showcase its portfolio of solutions designed to enable the radiopharma and theranostic fields at the 2025 Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting, June 21-24, in New Orleans, Louisiana. New products from Capintec and Dosimetry Services will be introduced alongside innovations from the broader Mirion portfolio, including the ec 2 Software suite and advances from Mirion Technologies. Debuting at the 2025 SNMMI Annual Meeting Graves Phantom from Capintec, a Mirion Medical company: The Graves Phantom is a groundbreaking, solution for enabling precise dosimetry in radiopharmaceutical therapy (RPT). Designed as a 20-cm tissue-equivalent phantom, it supports the calibration of SPECT systems per radioisotope and allows for accurate sensitivity factor measurements under realistic scatter conditions, enabling reliable and reproducible RPT workflows. Instadose ® VUE Beta Dosimeter from Dosimetry Services, a Mirion Medical company: The only hybrid wireless dosimeter designed for theranostic applications, the InstadoseVUE Beta device tracks and measures radiation exposure, ensuring the safety of medical staff in environments where beta radiation is present. The InstadoseVUE Beta is the latest model in the InstadoseVUE line of wireless dosimeters for radiation monitoring of personnel. Additional Featured Solutions from the Broader Mirion Portfolio ec 2 Software Suite: ec 2 Software, a Mirion Medical company, provides software to simplify workflows, support regulatory compliance, and drive operational efficiency for stakeholders across the nuclear medicine, molecular imaging and radiopharmaceutical fields. Demonstrations for applications including BioTrax™ QMS, NMIS™, and BioRx™ will be available throughout the SNMMI Annual Meeting. Apex-Guard™ Software: From Mirion Technologies, the newest version of Apex-Guard software includes a robust impurity analysis feature and patent-pending algorithm for gamma spectroscopy measurements, which simplifies radioisotope production quality management, boosts confidence in radioisotope safety, and aids in regulatory compliance. The software integrates with BioTrax QMS, improving workflow efficiency and data integrity. Portable and Mobile Radiation Monitoring: New solutions from Mirion Technologies include the CSPevo ® Probe and RDS-Med™ Survey Meter for comprehensive, portable radiation survey monitoring and the IC3™ Portable Ion Chamber Survey Meter for measuring gamma, beta and X-ray radiation. In addition, the iCAM™ Mobile Alpha/Beta Particulate Monitor for reliable monitoring of airborne activity will be on hand. 'As the nuclear medicine and molecular imaging landscape evolves, Mirion is committed to leveraging our deep expertise in ionizing radiation to serve our customers and ensure safe, efficient operations at every step,' said Luis Rivera, Executive Vice President of Mirion Medical. 'From research to production to patient care, Mirion Medical and Mirion Technologies alike are developing solutions to drive higher quality. We look forward to demonstrating how these solutions can shape a more connected future.' Commitment to Patient Care and Safety Mirion Medical is a proud sponsor of the SNMMI 2025 Patient Education Day, contributing educational resources and insights on radiation safety. This sponsorship reflects Mirion's commitment to patient education and awareness, ensuring that patients and their families are well-informed about the benefits of nuclear medicine and molecular imaging. About Mirion Mirion is a global leader in radiation safety, science and medicine, empowering innovations that deliver vital protection while harnessing the transformative potential of ionizing radiation across a diversity of end markets. The Mirion Technologies group is committed to powering advancements in nuclear energy through proven radiation safety technologies and expertise. The Mirion Medical group is focused on improving quality in cancer care through its broad range of solutions that enhance delivery and ensure safety across the medical landscape. Headquartered in Atlanta (GA – USA), Mirion employs approximately 2,800 people and operates in 12 countries. ©2025 Mirion. All rights reserved. Instadose®VUE, BioTrax™ QMS, NMIS™, BioRx™, CSPevo™, Apex-Guard™, IC3™, and iCAM™ are trademarks or registered trademarks of Mirion Technologies, Inc. and/or its affiliates in the United States and/or other countries.
